Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (41 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 08 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 100 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Edelweiss Large Cap Fund |
|---|---|
| 08 Jan 2013 | ₹100.00 |
| 26 Feb 2014 | ₹107.16 |
| 17 Apr 2015 | ₹150.69 |
| 04 Jun 2016 | ₹146.30 |
| 23 Jul 2017 | ₹176.96 |
| 11 Sep 2018 | ₹183.67 |
| 30 Oct 2019 | ₹182.59 |
| 17 Dec 2020 | ₹193.30 |
| 05 Feb 2022 | ₹232.13 |
| 26 Mar 2023 | ₹216.87 |
| 13 May 2024 | ₹278.66 |
| 02 Jul 2025 | ₹314.95 |
| 20 Aug 2026 | ₹298.84 |
| Metric | Edelweiss · Direct · IDCW NAV ₹38.79 Very High risk ★★★☆☆ | Category median Large Cap Fund · 41 funds |
|---|---|---|
| -3.68% | -3.12% | |
| +7.15% | +9.35% | |
| +5.77% | +8.00% | |
| +6.58% | +7.97% | |
| +8.37% | +9.16% | |
| +5.53% | — | |
| +8.59% | +10.38% | |
| +8.06% | +9.26% | |
| +8.32% | +8.80% | |
| Risk | ||
| 13.51% | 14.48% | |
| 0.05 | 0.16 | |
| 0.06 | 0.21 | |
| -38.80% | -36.60% | |
| Nifty 100 | — | |
| -2.37% | +0.11% | |
| 0.94 | 0.98 | |
| 83.4% | 96.8% | |
| 91.1% | 98.3% | |
| 0.96% | 1.08% | |
| ₹1,427Cr | ₹1,495Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 193% | 58% | |
| Bhavesh Jain · 9.3y | — | |
| 08 Jan 2013 | — | |
| 75 | — | |
| 42.5% | — | |
| 0.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.